Nystatin formulation having reduced toxicity

Details Nystatin formulation having reduced toxicity Nystatin formulation having reduced toxicity

A - Human Necessities

61

K

A61K 31/7048 (2006.01) A61K 9/06 (2006.01) A61K 47/10 (2006.01) A61K 47/18 (2006.01) A61K 47/26 (2006.01)

Patent

CA 2402025

The present invention provides a novel formulation of nystatin for parenteral administration to treat systemic fungal infections. The formulation avoids the toxicity and solubility problems of prior art nystatin formulations.

L'invention concerne une nouvelle formulation de nystatine pour l'administration parentérale dans le traitement des infections fongiques systémiques. Ladite formulation évite les problèmes liés à la toxicité et à la solubilité des formulations de nystatine antérieures.

Affiliated with

Also associated with

Rating

Nystatin formulation having reduced toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nystatin formulation having reduced toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nystatin formulation having reduced toxicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1752469